PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN THE UNITED KINGDOM

被引：0
|
作者：
Jamet, N. [1 ]
George, M. [2 ]
Shah, H. A. [3 ]
Oliyide, A. [3 ]
Zerda, I [4 ]
Cristeau, O. [5 ]
Casabona, G. [1 ]
机构：
[1] GSK, Wavre, Belgium
[2] Hari Thrivikramji, Wavre, Belgium
[3] GSK, London, England
[4] Creativ Ceut, Krakow, Poland
[5] Creativ Ceut, Paris, France
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH161
引用
收藏
页码：S221 / S222
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF UNIVERSAL INFLUENZA VACCINATION IN THE US
    Clements, K. M.
    Chancellor, J.
    DeLong, K.
    Nichol, K. L.
    Thompson, D.
    VALUE IN HEALTH, 2010, 13 (03) : A189 - A189
  • [42] Cost-Effectiveness of a Recommendation of Universal Mass Vaccination for Seasonal Influenza in the United States
    Clements, Karen M.
    Chancellor, Jeremy
    Nichol, Kristin
    DeLong, Kelly
    Thompson, David
    VALUE IN HEALTH, 2011, 14 (06) : 800 - 811
  • [43] Public health services and cost-effectiveness analysis
    Banta, H. David
    de Wit, G. Ardine
    ANNUAL REVIEW OF PUBLIC HEALTH, 2008, 29 : 383 - 397
  • [44] MAMMOGRAPHY UTILIZATION, PUBLIC-HEALTH IMPACT, AND COST-EFFECTIVENESS IN THE UNITED-STATES
    WHITE, E
    URBAN, N
    TAYLOR, V
    ANNUAL REVIEW OF PUBLIC HEALTH, 1993, 14 : 605 - 633
  • [45] Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    Oliver Damm
    Martin Eichner
    Markus Andreas Rose
    Markus Knuf
    Peter Wutzler
    Johannes Günter Liese
    Hagen Krüger
    Wolfgang Greiner
    The European Journal of Health Economics, 2015, 16 : 471 - 488
  • [46] Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
    Damm, Oliver
    Eichner, Martin
    Rose, Markus Andreas
    Knuf, Markus
    Wutzler, Peter
    Liese, Johannes Guenter
    Krueger, Hagen
    Greiner, Wolfgang
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (05): : 471 - 488
  • [47] REGIONAL COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL CHILDHOOD HEPATITIS A VACCINATION IN BRAZIL
    De Soarez, P. C.
    Sartori, A. M. C.
    Novaes, H. M. D.
    Amaku, M.
    Azevedo, R. S.
    Ximenes, R. A.
    Martelli, C. M. T.
    VALUE IN HEALTH, 2012, 15 (04) : A194 - A194
  • [48] Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh
    Sarker, Abdur Razzaque
    Sultana, Marufa
    Mahumud, Rashidul Alam
    Van der Meer, Robert
    Morton, Alec
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) : 189 - 198
  • [49] Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis
    Whittles, Lilith K.
    Didelot, Xavier
    White, Peter J.
    LANCET INFECTIOUS DISEASES, 2022, 22 (07): : 1030 - 1041
  • [50] THE ESTIMATED IMPACT AND COST-EFFECTIVENESS OF NONAVALENT HPV VACCINATION IN THE UNITED STATES
    Chesson, H. W.
    Markowitz, L. E.
    Hariri, S.
    Ekwueme, D. U.
    Saraiya, M.
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A61 - A62
12345